| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.118 | 8.405 | 4.456 | 3.541 | 2.359 | 2.025 | 744 | 0 | 0 | 0 |
| Total Income - EUR | 11.118 | 8.405 | 4.456 | 3.541 | 2.359 | 2.025 | 744 | 0 | 0 | 0 |
| Total Expenses - EUR | 7.441 | 7.070 | 3.633 | 2.782 | 2.148 | 1.798 | 1.510 | 13 | 118 | 24 |
| Gross Profit/Loss - EUR | 3.677 | 1.334 | 822 | 759 | 211 | 226 | -766 | -13 | -118 | -24 |
| Net Profit/Loss - EUR | 3.343 | 1.082 | 663 | 652 | 140 | 166 | -788 | -13 | -118 | -24 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cabinet Oftalmologic Medicor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 23.775 | 24.825 | 24.654 | 24.889 | 2.049 | 2.101 | 1.070 | 997 | 876 | 847 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 20.216 | 22.161 | 23.184 | 24.036 | 999 | 1.090 | 44 | 16 | 16 | 16 |
| Cash | 3.560 | 2.664 | 1.470 | 854 | 1.050 | 1.011 | 1.025 | 981 | 860 | 831 |
| Shareholders Funds | 22.999 | 23.847 | 24.106 | 24.316 | 1.690 | 1.824 | 995 | 985 | 864 | 835 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 777 | 979 | 548 | 574 | 359 | 277 | 75 | 12 | 12 | 12 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Oftalmologic Medicor S.r.l.